41 participants
Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2023-12-22
- Start Date:
- 2012-11-14
- Completion:
- 2018-12-31
Conditions
- Recurrent Malignant Solid Neoplasm
- Recurrent Melanoma
- Recurrent Primary Central Nervous System Neoplasm
- Recurrent Thyroid Gland Carcinoma
- Refractory Malignant Solid Neoplasm
- Refractory Primary Central Nervous System Neoplasm
- Thyroid Gland Medullary Carcinoma
Interventions
- DRUG
- OTHER